Catalyst Wire Dossier Catalyst Wire Dossier

Rituxan

rituximab · Genentech (Roche)
Drug timelines are a Plus or Pro feature.

382 regulatory and trial events tracked for Rituxan, covering 2006-09-26 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma [Phase 2]

See pricing